A randomized controlled trial of intra-arterial infusion of CDDP for hepatocellular carcinoma to prevent intra-hepatic metastasis after curative resectio
Phase 1
- Conditions
- Patients after curative resection of hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000001138
- Lead Sponsor
- iigata Hepatocellular Carcinoma Therapy Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. The history of severe allergic reaction against iodinated contrast medium and/or platinum-containing drugs. 2. A woman who is pregnant, lactating, or may become pregnant. 3. Hepatocellular carcinoma extended to the first branch of the portal vein or further. 4. Hepatocellular carcinoma extended to the inferior vena cava or further. 5. Dynamic CT or dynamic MRI revealed that hepatocellular carcinoma is solitary and 2 cm or less without vascular invasion. 6. Under interferon therapy. 7. A doctor responsible for the study judged to be inappropriate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method